Current management of bloodstream infections

被引:29
作者
Rodriguez-Bano, Jesus [1 ,2 ]
de Cueto, Marina [1 ,3 ]
Retamar, Pilar [1 ]
Galvez-Acebal, Juan [1 ,2 ]
机构
[1] Hosp Univ Virgen Macarena, Unidad Clin Enfermedades Infecciosas & Microbiol, Seville 41009, Spain
[2] Univ Seville, Dept Med, Seville, Spain
[3] Univ Seville, Dept Microbiol, Seville, Spain
关键词
antimicrobial resistance; bacteremia; bloodstream infections; community-acquired infections; nosocomial infections; sepsis; COAGULASE-NEGATIVE STAPHYLOCOCCI; POLYMERASE-CHAIN-REACTION; BETA-LACTAMASE PRODUCTION; KLEBSIELLA-PNEUMONIAE; ANTIMICROBIAL THERAPY; MOLECULAR EPIDEMIOLOGY; MULTIDRUG-RESISTANT; RISK-FACTORS; ANTIBIOTIC-RESISTANCE; CLINICAL-FEATURES;
D O I
10.1586/ERI.10.49
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Bloodstream infection (BSI) is a frequent complication of invasive infections. The presence of bacteremia has therapeutic and prognostic implications. Here we review recent changes in the epidemiology, diagnosis and treatment of BSI (excluding candidemia). The evidence of the impact of healthcare-association in many community-onset episodes and the increase in drug-resistant pathogens causing BSI in the community and hospitals is reviewed. The emergence of molecular methods as an alternative tool for the diagnosis of BSI and novel aspects of clinical management, particularly of some multidrug-resistant organisms. Several quality indicators related to the diagnosis and management of bacteremia in hospitals are proposed.
引用
收藏
页码:815 / 829
页数:15
相关论文
共 155 条
[21]   Bloodstream infections in a geriatric cohort: A population-based study [J].
Crane, Sarah J. ;
Uslan, Daniel Z. ;
Baddour, Larry M. .
AMERICAN JOURNAL OF MEDICINE, 2007, 120 (12) :1078-1083
[22]   VIM-1-producing Klebsiella pneumoniae bloodstream infections:: analysis of 28 cases [J].
Daikos, George L. ;
Karabinis, Andreas ;
Paramythiotou, Elizabeth ;
Syriopoulou, Vassiliki P. ;
Kosmidis, Christos ;
Avlami, Athina ;
Gargalianos, Panayiotis ;
Tzanetou, Konstantina ;
Petropoulou, Demetra ;
Malamou-Lada, Helen .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 (04) :471-473
[23]   Prospective Observational Study of the Impact of VIM-1 Metallo-β-Lactamase on the Outcome of Patients with Klebsiella pneumoniae Bloodstream Infections [J].
Daikos, George L. ;
Petrikkos, Panayiotis ;
Psichogiou, Mina ;
Kosmidis, Chris ;
Vryonis, Evangelos ;
Skoutelis, Athanasios ;
Georgousi, Kleoniki ;
Tzouvelekis, Leonidas S. ;
Tassios, Panayotis T. ;
Bamia, Christina ;
Petrikkos, George .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (05) :1868-1873
[24]   Fatal levofloxacin failure in treatment of a bacteremic patient infected with Streptococcus pneumoniae with a preexisting parC Mutation [J].
de Cueto, A. ;
Rodriguez, J. M. ;
Soriano, M. J. ;
Lopez-Cerero, L. ;
Venero, J. ;
Pascual, A. .
JOURNAL OF CLINICAL MICROBIOLOGY, 2008, 46 (04) :1558-1560
[25]   Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock [J].
Dellinger, RP ;
Carlet, JM ;
Masur, H ;
Gerlach, H ;
Calandra, T ;
Cohen, J ;
Gea-Banacloche, J ;
Keh, D ;
Marshall, JC ;
Parker, MM ;
Ramsay, G ;
Zimmerman, JL ;
Vincent, JL ;
Levy, MM .
CRITICAL CARE MEDICINE, 2004, 32 (03) :858-873
[26]   Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: a report from the SENTRY antimicrobial surveillance program [J].
Deshpande, Lalitagauri M. ;
Fritsche, Thomas R. ;
Moet, Gary J. ;
Biedenbach, Douglas J. ;
Jones, Ronald N. .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2007, 58 (02) :163-170
[27]   Clinical characterization of breakthrough bacteraemia: a survey of 392 episodes [J].
Dupla, ML ;
Martinez, JA ;
Vidal, F ;
Almela, M ;
Lopez, J ;
Marco, F ;
Soriano, A ;
Richart, C ;
Mensa, J .
JOURNAL OF INTERNAL MEDICINE, 2005, 258 (02) :172-180
[28]   Impact of the more-potent antibiotics quinupristin-dalfopristin and linezolid on outcome measure of patients with vancomycin-resistant Enterococcus bacteremia [J].
Erlandson, Kristine Mace ;
Sun, Junfeng ;
Iwen, Peter C. ;
Rupp, Mark E. .
CLINICAL INFECTIOUS DISEASES, 2008, 46 (01) :30-36
[29]   Linezolid versus glycopeptide or β-lactam for treatment of Gram-positive bacterial infections:: meta-analysis of randomised controlled trials [J].
Falagas, Matthew E. ;
Siempos, Ilias I. ;
Vardakas, Konstantinos Z. .
LANCET INFECTIOUS DISEASES, 2008, 8 (01) :53-66
[30]   Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum β-lactamase producing, Enterobacteriaceae infections: a systematic review [J].
Falagas, Matthew E. ;
Kastoris, Antonia C. ;
Kapaskelis, Anastasios M. ;
Karageorgopoulos, Drosos E. .
LANCET INFECTIOUS DISEASES, 2010, 10 (01) :43-50